Marissa Nunes-Moreno1, Cindy Buchanan1, F Sessions Cole2, Shanlee Davis1, Amanda Dempsey1, Nadia Dowshen3, Anna Furniss1, Anne E Kazak4, Anna J Kerlek5, Peter Margolis6, Laura Pyle1, Hanieh Razzaghi7, Daniel H Reirden1, Beth Schwartz4, Gina M Sequeira8, Natalie J Nokoff9. 1. University of Colorado Anschutz Medical Campus, Aurora, CO. 2. Washington University School of Medicine, St. Louis, MO. 3. University of Pennsylvania, Perelman School of Medicine, Philadelphia, PA. 4. Nemours Children's Health System, Center for Healthcare Delivery Science Wilmington, DE. 5. Nationwide Children's Hospital, Columbus, OH. 6. University of Cincinnati, Cincinnati, OH. 7. Applied Clinical Research Center, Children's Hospital of Philadelphia, Philadelphia, PA. 8. University of Washington, Department of Pediatrics, Seattle, WA. 9. University of Colorado Anschutz Medical Campus, Aurora, CO. Electronic address: Natalie.Nokoff@childrenscolorado.org.
Abstract
OBJECTIVE: To assess the odds of a psychiatric or neurodevelopmental diagnosis among youth with a diagnosis of gender dysphoria compared with matched controls in a large electronic health record dataset from 6 pediatric health systems, PEDSnet. We hypothesized that youth with gender dysphoria would have higher odds of having psychiatric and neurodevelopmental diagnoses than controls. STUDY DESIGN: All youth with a diagnosis of gender dysphoria (n = 4173 age at last visit 16.2 ± 3.4) and at least 1 outpatient encounter were extracted from the PEDSnet database and propensity-score matched on 8 variables to controls without gender dysphoria (n = 16 648, age at last visit 16.2 ± 4.8) using multivariable logistic regression. The odds of having psychiatric and neurodevelopmental diagnoses were examined using generalized estimating equations. RESULTS: Youth with gender dysphoria had higher odds of psychiatric (OR 4.0 [95% CI 3.8, 4.3] P < .0001) and neurodevelopmental diagnoses (1.9 [1.7, 2.0], P < .0001). Youth with gender dysphoria were more likely to have a diagnosis across all psychiatric disorder subcategories, with particularly high odds of mood disorder (7.3 [6.8, 7.9], P < .0001) and anxiety (5.5 [5.1, 5.9], P < .0001). Youth with gender dysphoria had a greater odds of autism spectrum disorder (2.6, [2.2, 3.0], P < .0001). CONCLUSIONS: Youth with gender dysphoria at large pediatric health systems have greater odds of psychiatric and several neurodevelopmental diagnoses compared with youth without gender dysphoria. Further studies are needed to evaluate changes in mental health over time with access to gender affirming care.
OBJECTIVE: To assess the odds of a psychiatric or neurodevelopmental diagnosis among youth with a diagnosis of gender dysphoria compared with matched controls in a large electronic health record dataset from 6 pediatric health systems, PEDSnet. We hypothesized that youth with gender dysphoria would have higher odds of having psychiatric and neurodevelopmental diagnoses than controls. STUDY DESIGN: All youth with a diagnosis of gender dysphoria (n = 4173 age at last visit 16.2 ± 3.4) and at least 1 outpatient encounter were extracted from the PEDSnet database and propensity-score matched on 8 variables to controls without gender dysphoria (n = 16 648, age at last visit 16.2 ± 4.8) using multivariable logistic regression. The odds of having psychiatric and neurodevelopmental diagnoses were examined using generalized estimating equations. RESULTS: Youth with gender dysphoria had higher odds of psychiatric (OR 4.0 [95% CI 3.8, 4.3] P < .0001) and neurodevelopmental diagnoses (1.9 [1.7, 2.0], P < .0001). Youth with gender dysphoria were more likely to have a diagnosis across all psychiatric disorder subcategories, with particularly high odds of mood disorder (7.3 [6.8, 7.9], P < .0001) and anxiety (5.5 [5.1, 5.9], P < .0001). Youth with gender dysphoria had a greater odds of autism spectrum disorder (2.6, [2.2, 3.0], P < .0001). CONCLUSIONS: Youth with gender dysphoria at large pediatric health systems have greater odds of psychiatric and several neurodevelopmental diagnoses compared with youth without gender dysphoria. Further studies are needed to evaluate changes in mental health over time with access to gender affirming care.
Authors: Nicos Skordis; Gary Butler; Martine C de Vries; Katharina Main; Sabine E Hannema Journal: Horm Res Paediatr Date: 2019-01-29 Impact factor: 2.852
Authors: Sari L Reisner; Ralph Vetters; M Leclerc; Shayne Zaslow; Sarah Wolfrum; Daniel Shumer; Matthew J Mimiaga Journal: J Adolesc Health Date: 2015-01-07 Impact factor: 5.012
Authors: Maureen D Connolly; Marcus J Zervos; Charles J Barone; Christine C Johnson; Christine L M Joseph Journal: J Adolesc Health Date: 2016-08-17 Impact factor: 5.012
Authors: Varun Warrier; David M Greenberg; Elizabeth Weir; Clara Buckingham; Paula Smith; Meng-Chuan Lai; Carrie Allison; Simon Baron-Cohen Journal: Nat Commun Date: 2020-08-07 Impact factor: 14.919
Authors: Anna Valentine; Shanlee Davis; Anna Furniss; Nadia Dowshen; Anne E Kazak; Christopher Lewis; Danielle F Loeb; Leena Nahata; Laura Pyle; Lisa M Schilling; Gina M Sequeira; Natalie Nokoff Journal: J Clin Endocrinol Metab Date: 2022-09-28 Impact factor: 6.134